Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Saga

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Alternative use of 5' exons in the specification of Ly-5 isoforms distinguishing hematopoietic cell lineagesY Saga, J S Tung, F W Shen, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 13, 1997
[A clinicopathological study on carcinoma of the renal pelvis and ureter]H Hashimoto, Y Saga, M Tokumitsu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1990
[Micturition and uroflowmetric analysis of adult females]M Miyata, M Mizunaga, Y Saga, et al.
Urologia Internationalis|January 1, 1989
Case report: secondary penile carcinomaH Hashimoto, Y Saga, Y Watabe, et al.
Oncology|March 13, 2001
Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significanceM Suzuki, M Ohwada, Y Saga, et al.
Current Medicinal Chemistry|February 16, 2013
Chitosan nanoparticles for melanoma cancer treatment by Photodynamic Therapy and electrochemotherapy using aminolevulinic acid derivativesD M Ferreira, Y Y Saga, E Aluicio-Sarduy, et al.
The Journal of Experimental Medicine|November 1, 1987
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigensM Streuli, L R Hall, Y Saga, et al.
Mechanisms of Development|October 2, 2001
Transcriptional regulation of Mesp1 and Mesp2 genes: differential usage of enhancers during developmentS Haraguchi, S Kitajima, A Takagi, et al.
Auris, Nasus, Larynx|January 1, 1991
Glycolipids in rat cochleaS Maguchi, S Gasa, J Matsushima, et al.
Immunogenetics|January 1, 1990
Further data on the selective expression of Ly-5 isoformsY Saga, K Furukawa, P Rogers, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Alternative use of 5' exons in the specification of Ly-5 isoforms distinguishing hematopoietic cell lineagesY Saga, J S Tung, F W Shen, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 13, 1997
[A clinicopathological study on carcinoma of the renal pelvis and ureter]H Hashimoto, Y Saga, M Tokumitsu, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|July 1, 1990
[Micturition and uroflowmetric analysis of adult females]M Miyata, M Mizunaga, Y Saga, et al.
Urologia Internationalis|January 1, 1989
Case report: secondary penile carcinomaH Hashimoto, Y Saga, Y Watabe, et al.
Oncology|March 13, 2001
Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significanceM Suzuki, M Ohwada, Y Saga, et al.
Current Medicinal Chemistry|February 16, 2013
Chitosan nanoparticles for melanoma cancer treatment by Photodynamic Therapy and electrochemotherapy using aminolevulinic acid derivativesD M Ferreira, Y Y Saga, E Aluicio-Sarduy, et al.
The Journal of Experimental Medicine|November 1, 1987
Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigensM Streuli, L R Hall, Y Saga, et al.
Mechanisms of Development|October 2, 2001
Transcriptional regulation of Mesp1 and Mesp2 genes: differential usage of enhancers during developmentS Haraguchi, S Kitajima, A Takagi, et al.
Auris, Nasus, Larynx|January 1, 1991
Glycolipids in rat cochleaS Maguchi, S Gasa, J Matsushima, et al.
Immunogenetics|January 1, 1990
Further data on the selective expression of Ly-5 isoformsY Saga, K Furukawa, P Rogers, et al.
Pageof 9